Impinj

PI · NYSE · Technology · United States

Financials at a glance

Source: SEC XBRL

Annual

FY2023FY2024FY2025$307.5M$307.5M$366.1M$366.1M$361.1M$361.1M-3.0% margin-3.0% marginRevenueNet margin

Quarterly · last 8

Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26Q2 '26$76.8M$76.8M$102.5M$102.5M$95.2M$95.2M$74.3M$74.3M$97.9M$97.9M$96.1M$96.1M$74.3M$74.3M$108.4M$108.4M11.3% margin11.3% marginRevenueNet margin

Revenue (FY2025)

$361.1M

Net margin

-3.0%

ROE

-5.2%

Revenue CAGR (2y)

+8.4%

EPS (FY2025)

-0.37

Net profit (FY2025)

$-10.8M

Ask MarketChacha about PI

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Why it moved

  • Sep 1, 2026

    Impinj shares declined 3.52% with no company-specific news, earnings, or SEC filings on September 1; the move appears to reflect broader market or sector sentiment.

    · confidence: low
  • Aug 25, 2026

    Impinj shares rose with broader market and semiconductor sector momentum; no company-specific catalyst or news emerged on August 25.

    · confidence: low

Daily moves with the verified reason behind them. Education only — not investment advice.

Financials

Yearly

PeriodRevenueNet profitEPSNet marginROE
FY2025$361.1M$-10.8M-0.37-3.0%-5.2%
FY2024$366.1M$40.8M1.3911.2%27.3%
FY2023$307.5M$-43.4M-1.62-14.1%-127.1%

Quarterly

PeriodRevenueNet profitEPSNet margin
2026Q2$108.4M$12.2M0.3911.3%
2026Q1$74.3M$-25.3M-0.83-34.0%
2025Q3$96.1M$-12.8M-0.44-13.3%
2025Q2$97.9M$11.6M0.3911.8%
2025Q1$74.3M$-8.5M-0.30-11.4%
2024Q3$95.2M$221,0000.010.2%
2024Q2$102.5M$10.0M0.349.7%
2024Q1$76.8M$33.3M1.1043.4%
2023Q3$65.0M$-15.8M-0.59-24.2%
2023Q2$86.0M$-8.1M-0.30-9.4%
2023Q1$85.9M$-4.4M-0.17-5.1%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.